StockNews.AI · 7 hours
DXL's board is evaluating Zodiac's revised $0.84 cash offer for all outstanding DXLG shares. It previously rejected a $0.82 bid, citing opportunism and timing; a Schedule 14D-9 amendment will be filed and reviewed with advisers, keeping stockholders in the loop as a potential take-private unfolds.
A higher, revised cash offer and ongoing board review create a potential price floor near $0.84 if a deal progresses; however, certainty remains pending Schedule 14D-9 disclosures and any competing bids.
DXLG may trend toward the $0.84 cash offer on take-private prospects, but deal certainty remains uncertain in the near term.
Category: M&A. The article centers on a tender offer and board fiduciary review, likely to influence DXL's valuation and potential take-private outcome.